Intravenous Infusion Pump Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 8.98 Billion |
| Market Size (2029) | USD 12.77 Billion |
| CAGR (2024 - 2029) | 7.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Intravenous Infusion Pump Market Analysis
The Intravenous Infusion Pump Market size is estimated at USD 8.98 billion in 2024, and is expected to reach USD 12.77 billion by 2029, growing at a CAGR of 7.30% during the forecast period (2024-2029).
The growing prevalence of chronic diseases, the rise in healthcare investments, and the growth in the adoption of portable infusion pumps are the key driving factors in the intravenous infusion pump market.
The market for intravenous infusion pumps is likely to grow owing to the high burden of chronic disease, which leads to an increase in the demand for intravenous infusion pumps for administering medications in precise amounts, thus contributing to the market growth. For instance, as per the data updated by the Centers for Disease Control and Prevention in November 2023, 60% of United States adults have at least one chronic disease, while 40% have two or more chronic disorders. Since patients with chronic disease are prone to nutrient shortages, a high prevalence of chronic disease is expected to increase the usage of IV infusion pumps. Also, according to the above-mentioned sources, chronic diseases are the most significant source of annual healthcare costs in the United States, equivalent to USD 4.1 trillion. Thus, the high burden of chronic diseases is expected to increase the usage of infusion pumps in hospitals and boost the market growth during the forecast period.
Additionally, the increase in the geriatric population is anticipated to drive the demand for intravenous infusion pumps to administer medications accurately and thus propel the market growth. For instance, per the United Nations Population Fund's India Ageing Report 2023, published in September 2023, the population of 60 years and above is expected to rise from 149 million in 2022 to 347 million by 2050. Thus, the growing geriatric population is more prone to chronic diseases, which is anticipated to increase the usage of intravenous infusion pumps and drive market growth.
Moreover, market player initiatives such as partnerships and product launches increase product availability and are anticipated to boost market growth. For instance, in August 2023, Baxter International Inc. received approval from the United States Food and Drug Administration for a Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software. In March 2022, China's National Medical Products Administration (NMPA) also granted marketing approval to Shanghai MicroPort Lifesciences Co., Ltd (MicroPort Lifesciences) for its independently developed AutoEx Chemotherapy Infusion Pump. Thus, such market player initiatives are anticipated to contribute to market growth.
Hence, as per the factors mentioned above, such as the increasing prevalence of chronic diseases and the rising geriatric population, the intravenous infusion pump market is expected to grow during the forecast period. However, the high costs and stringent regulatory approvals of IV infusion pumps restrain the market growth.
Intravenous Infusion Pump Market Trends
The Volumetric Infusion Pump Segment is Expected to Witness a Healthy Growth During the Forecast Period
Volumetric infusion pumps are extensively used in disease management and parenteral nutrition because their market value is the highest compared to other pumps. The pumps' safety, accuracy, and simplicity are attributed to their high demand.
The trend of adopting technologically advanced volumetric infusion pumps with capabilities such as electronic health record (EHR) integration, built-in safety systems, and drug libraries is likely to drive market growth. For instance, according to an article published by the Journal of Patient Safety in August 2022, the use of intravenous (IV) medications via infusion pumps is a complex task inherently associated with patient safety risks, and an estimated 90% of hospitalized patients require the controlled administration of medications using the intravenous route. Volumetric infusion pumps are prevalent in healthcare for controlled medication administration. While there are various infusion pumps, large-volume IV smart pumps are the most versatile and, thus, are the most commonly used type of infusion pump in United States acute care. Hence, such advantages of volumetric infusion pumps are expected to fuel the market growth during the forecast period.
Also, the high prevalence of chronic diseases is one of the significant factors for adopting the IV infusion pump. For instance, according to a study published by the Institute for Health Metrics and Evaluation (IHME) in August 2023, around 1 billion adults worldwide are anticipated to have arthritis by 2050. Thus, with the growing burden of arthritis, the demand for volumetric infusion pumps is expected to increase for administering medications in precise amounts, which, in turn, is likely to support the market growth during the forecast period.
Additionally, market players adopt various strategies, such as partnership agreements, to boost market growth. For instance, in December 2023, Fresenius Kabi signed a multiyear agreement that involved the purchase of 10,000 Ivenix large-volume infusion pumps by the Mayo Clinic for its hospitals and clinics in Minnesota, Arizona, and Florida. Thus, such partnerships are expected to promote product availability and contribute to the market growth.
Thus, the factors above, such as the rising incidence of chronic diseases, the increasing advantages of volumetric pumps, and market player strategic initiatives, are expected to boost the market's growth.
North America is Expected to Hold a Significant Market Share During the Forecast Period
North America is expected to hold a significant market share in the intravenous infusion pump market due to an increase in the incidence of chronic diseases, the rising geriatric population, and favorable reimbursement policies in this region.
Also, the rising prevalence of cancer is expected to fuel the demand for intravenous infusion pumps and stimulate the region's growth. For instance, according to the article published in the Canadian Medical Association Journal in June 2024, around 247,000 new cancer cases were expected to be diagnosed in Canada in 2024. Also, as per the American Cancer Society's data published in January 2024, around 62,770 new cases of leukemia and 20,800 new cases of acute myeloid leukemia (AML) are expected to be reported in the United States in 2024. Thus, the high incidence of blood cancer cases is leading to an increase in the usage of intravenous infusion pumps, thereby driving the market in the region.
Also, government and private agency initiatives and recommendations regarding home care infusion settings promote market growth in the region. For instance, as per the 2022 news published by the National Home Infusion Association, numerous healthcare systems, hospitals, and group purchasing organizations representing all 50 states are urging Congress to address Medicare beneficiary access to home infusion treatments and approve legislation to enhance access to home-based care. Hence, such movements promote the adoption of IV infusion systems in the home care setting, thereby boosting market growth.
Hence, North America is expected to witness growth during the forecast period attributed to the above-mentioned factors, such as the government and private agency initiatives and recommendations regarding home care infusion settings and the growing burden of chronic diseases.
Intravenous Infusion Pump Industry Overview
The intravenous infusion pump market is consolidated and consists of a few major players. In terms of market share, some of the companies that are dominating the market are B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, ICU Medical, Inc., IRadimed Corporation, Mindray, Moog Inc., Smiths Medical, Terumo Corporation, and Zyno Medical.
Intravenous Infusion Pump Market Leaders
-
B. Braun Melsungen AG
-
Becton, Dickinson and Company
-
IRadimed Corporation
-
Baxter International Inc.
-
ICU Medical, Inc.
*Disclaimer: Major Players sorted in no particular order
Intravenous Infusion Pump Market News
- April 2024: Baxter International Inc. received the United States Food and Drug Administration (FDA) 510(k) clearance for its new Novum IQ large-volume infusion pump (SYR), which features Dose IQ Safety software to improve patient safety.
- July 2023: BD received 510(k) approval from the United States Food and Drugs Administration for an updated BD Alaris Infusion System. Thus, such advancements are anticipated to contribute to the market growth.
Intravenous Infusion Pump Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in the Prevalence of Chronic Diseases
4.2.2 Increasing Adoption in Home Healthcare Settings
4.2.3 Increasing Healthcare Investments in Developing Countries
4.3 Market Restraints
4.3.1 High Cost of Intravenous Infusion Pumps
4.3.2 Safety Issues and Stringent Regualtions
4.4 Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
5.1 By Type
5.1.1 Volumetric Pumps
5.1.2 Syringe Pumps
5.1.3 Patient-controlled Analgesia Pump
5.2 By Application
5.2.1 Analgesia/Pain Management
5.2.2 Oncology
5.2.3 Parenteral Nutrition
5.2.4 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Home Healthcare
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 B. Braun Melsungen AG
6.1.2 Baxter International Inc.
6.1.3 Becton, Dickinson and Company
6.1.4 ICU Medical Inc.
6.1.5 IRadimed Corporation
6.1.6 Shenzhen Mindray Bio-Medical Electronics Co. Ltd
6.1.7 Moog Inc.
6.1.8 Smiths Medical
6.1.9 Terumo Corporation
6.1.10 Zyno Medical
6.1.11 Advanced Instrumentations
6.1.12 Micrel Medical Devices SA
6.1.13 Plenum Tech Private Limited
6.1.14 Sino Medical-Device Technology Co. Ltd
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Intravenous Infusion Pump Industry Segmentation
According to the scope of the report, an intravenous infusion pump is a medical device that gives fluids, such as nutrients and medications, into a patient's circulatory system through an intravenous route in controlled amounts. The intravenous infusion pump market is segmented by type, application, end user, and geography. By type, the market is segmented into volumetric pumps, syringe pumps, and patient-controlled analgesia pumps. By application, the market is segmented into analgesia/pain management, oncology, parenteral nutrition, and other applications. By end user, the market is segmented into hospitals, home healthcare, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. For each segment, the market size is provided in terms of (USD) value.
| By Type | |
| Volumetric Pumps | |
| Syringe Pumps | |
| Patient-controlled Analgesia Pump |
| By Application | |
| Analgesia/Pain Management | |
| Oncology | |
| Parenteral Nutrition | |
| Other Applications |
| By End User | |
| Hospitals | |
| Home Healthcare | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Intravenous Infusion Pump Market Research FAQs
How big is the Intravenous Infusion Pump Market?
The Intravenous Infusion Pump Market size is expected to reach USD 8.98 billion in 2024 and grow at a CAGR of 7.30% to reach USD 12.77 billion by 2029.
What is the current Intravenous Infusion Pump Market size?
In 2024, the Intravenous Infusion Pump Market size is expected to reach USD 8.98 billion.
Who are the key players in Intravenous Infusion Pump Market?
B. Braun Melsungen AG, Becton, Dickinson and Company, IRadimed Corporation, Baxter International Inc. and ICU Medical, Inc. are the major companies operating in the Intravenous Infusion Pump Market.
Which is the fastest growing region in Intravenous Infusion Pump Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Intravenous Infusion Pump Market?
In 2024, the North America accounts for the largest market share in Intravenous Infusion Pump Market.
What years does this Intravenous Infusion Pump Market cover, and what was the market size in 2023?
In 2023, the Intravenous Infusion Pump Market size was estimated at USD 8.32 billion. The report covers the Intravenous Infusion Pump Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Intravenous Infusion Pump Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Intravenous Infusion Pump Industry Report
Statistics for the 2024 Intravenous Infusion Pump market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Intravenous Infusion Pump analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
